| Filed On | Filing |
|---|---|
| 21 Oct 2026 |
Form 4: Fitzsimons Catherine Michele, CLO and CCO
Granted 601,932 Stock Option (Right to Buy) ($6.49M) |
| 16 Sep 2026 |
Form 4: Chew Qian Yi Amanda, Chief Product Officer
Granted 17,857 Restricted Stock Unit |
| 15 Sep 2026 |
Form 4: Fitzsimons Catherine Michele, CL and CO
Granted 34,372 Restricted Stock Unit · Received 2,148 shares by exercise or conversion · Returned 1,122 shares to the issuer ($17.1K) · 1 more |
| 15 Sep 2026 |
Form 4: Gould Greg, Chief Financial Officer
Granted 54,995 Restricted Stock Unit · Received 3,437 shares by exercise or conversion · Returned 1,272 shares to the issuer ($19.4K) · 1 more |
| 15 Sep 2026 |
Form 4: Tan Si-Hui, Chief Science Officer
Granted 55,000 Stock Option (Right to Buy) · Granted 91,659 Restricted Stock Unit · Received 3,600 shares as a grant or award · 3 more |
| 15 Sep 2026 |
Form 4: Fitzsimons Joseph Francis, Director
Granted 229,148 Restricted Stock Unit · Received 14,321 shares by exercise or conversion · Returned 3,438 shares to the issuer ($52.3K) · 1 more |
| 25 Mar 2026 |
Form 4: Lambert Danielle, Director
Bought 84,602 shares ($1M) |
| 25 Mar 2026 |
Form 4: Tan Si-Hui, Chief Science Officer
Granted 500,000 Stock Option (Right to Buy) |
| 25 Mar 2026 |
Form 4: Gould Greg, Chief Financial Officer
Granted 285,300 Stock Option (Right to Buy) |
| 24 Mar 2026 |
Form 4: Fitzsimons Joseph Francis, Director
Received 19,744,585 shares as a grant or award |
| 20 Mar 2026 |
Form 4: You Harry L., Director
Received 1,163,484 shares as a grant or award · Granted 2,884,660 Warrants |
Loading...